Chapter 1 Prefix
    1.1 Market Scope
    1.2 Report Description
    1.3 Research Methodology
          1.3.1 Primary Research
          1.3.2 Secondary Research
          1.3.3 In-house Data Modeling
Chapter 2 Executive Summary
Chapter 3 Market Outline
    3.1 Market Inclination, Trend, Outlook and Viewpoint
    3.2 Market Share Analysis: Company’s Competitive Scenario
    3.3 Market Dynamics
          3.3.1 Drivers
                   3.3.1.1 Impact Analysis
          3.3.2 Restraints
                   3.3.2.1 Impact Analysis
          3.3.3 Opportunities
Chapter 4 Biopharmaceuticals Market by Type: Market Size and Forecast, 2015 – 2024
    4.1 Overview
    4.2 Monoclonal Antibodies
          4.2.1 Current Trend and Analysis
          4.2.2 Market Size and Forecast
    4.3 Recombinant Proteins
          4.3.1 Current Trend and Analysis
          4.3.2 Market Size and Forecast
    4.4 Granulocyte Colony-Stimulating Factor (G-CSF)
          4.4.1 Current Trend and Analysis
          4.4.2 Market Size and Forecast
    4.5 Interferon
          4.5.1 Current Trend and Analysis
          4.5.2 Market Size and Forecast
    4.6 Recombinant Human Insulin
          4.6.1 Current Trend and Analysis
          4.6.2 Market Size and Forecast
    4.7 Erythropoietin
          4.7.1 Current Trend and Analysis
          4.7.2 Market Size and Forecast
    4.8 Vaccines
          4.8.1 Current Trend and Analysis
          4.8.2 Market Size and Forecast
    4.9 Growth Hormones
          4.9.1 Current Trend and Analysis
          4.9.2 Market Size and Forecast
    4.10 Purified Proteins
          4.10.1 Current Trend and Analysis
          4.10.2 Market Size and Forecast
    4.11 Other Types
          4.11.1 Current Trend and Analysis
          4.11.2 Market Size and Forecast
Chapter 5 Biopharmaceuticals Market by Therapeutic Application: Market Size and Forecast, 2015 – 2024
    5.1 Overview
    5.2 Oncology
          5.2.1 Current Trend and Analysis
          5.2.2 Market Size and Forecast
    5.3 Inflammatory Infectious Diseases
          5.3.1 Current Trend and Analysis
          5.3.2 Market Size and Forecast
    5.4 Metabolic Disorders
          5.4.1 Current Trend and Analysis
          5.4.2 Market Size and Forecast
    5.5 Cardiovascular Diseases
          5.5.1 Current Trend and Analysis
          5.5.2 Market Size and Forecast
    5.6 Other Therapeutic Applications
          5.6.1 Current Trend and Analysis
          5.6.2 Market Size and Forecast
Chapter 6 E-Clinical Solution Software Market by Geography: Market Size and Forecast, 2015 – 2024
    6.1 Overview
    6.2 North America
          6.2.1 Current Trend and Analysis
          6.2.2 Market Size and Forecast
          6.2.3 US
                   6.2.3.1 Market Size and Forecast
          6.2.4 Canada
                   6.2.4.1 Market Size and Forecast
          6.2.5 Mexico
                   6.2.5.1 Market Size and Forecast
    6.3 Europe
          6.3.1 Current Trend and Analysis
          6.3.2 Market Size and Forecast
          6.3.3 UK
                   6.3.3.1 Market Size and Forecast
          6.3.4 Germany
                   6.3.4.1 Market Size and Forecast
          6.3.5 France
                   6.3.5.1 Market Size and Forecast
          6.3.6 Italy
                   6.3.6.1 Market Size and Forecast
          6.3.6 Others
                   6.3.6.1 Market Size and Forecast
    6.4 Asia-Pacific
          6.4.1 Current Trend and Analysis
          6.4.2 Market Size and Forecast
          6.4.3 Japan
                   6.4.3.1 Market Size and Forecast
          6.4.4 China
                   6.4.4.1 Market Size and Forecast
          6.4.5 India
                   6.4.5.1 Market Size and Forecast
          6.4.6 Others
                   6.4.6.1 Market Size and Forecast
    6.5 RoW
          6.5.1 Current Trend and Analysis
          6.5.2 Market Size and Forecast
          6.5.3 Middle East
                   6.5.3.1 Market Size and Forecast
          6.5.4 South America
                   6.5.4.1 Market Size and Forecast
          6.5.5 Africa
                   6.5.5.1 Market Size and Forecast
Chapter 7 Company Profiles
    7.1 Roche Holding AG
    7.2 Bayer AG
    7.3 Abbott Laboratories
    7.4 Biocon Ltd
    7.5 Eli Lilly and Company
    7.6 Ranbaxy Laboratories Ltd.
    7.7 Pfizer Inc.
    7.8 Novartis AG
    7.9 Genentech, Inc.
    7.10 Johnson & Johnson, Inc

GET MORE INFORMATION ABOUT THIS REPORT


Refresh Captcha

Related Report